According to Swedish Orphan Biovitrum's latest financial reports the company's current revenue (TTM ) is $2.45 Billion USD. an increase over the revenue in the year 2023 that were of $2.10 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | $2.45 B | 16.69% |
2023 | $2.10 B | 14.06% |
2022 | $1.84 B | 4.64% |
2021 | $1.76 B | 4.94% |
2020 | $1.68 B | 11.05% |
2019 | $1.51 B | 46.02% |
2018 | $1.03 B | 33.76% |
2017 | $0.77 B | 27.36% |
2016 | $0.60 B | 58.58% |
2015 | $0.38 B | 3.91% |
2014 | $0.36 B | 10.57% |
2013 | $0.33 B | 15.54% |
2012 | $0.28 B | -0.8% |
2011 | $0.29 B | 8.78% |
2010 | $0.26 B | 54.89% |
2009 | $0.17 B |